3-D cell based Pk/Pd assays in hollow fiber bioreactors
readily permit changes in drug concentration as would be seen in human Pk/Pd. Animal models generally do not provide the same drug kinetics as would be found in humans
Articles, journals and conferences in one search. An exact title, DOI or ISSN is listed first.
In the search box: "exact phrase" · -leave out · OR · prefix* · title: author: journal:
readily permit changes in drug concentration as would be seen in human Pk/Pd. Animal models generally do not provide the same drug kinetics as would be found in humans
readily permit changes in drug concentration as would be seen in human Pk/Pd. Animal models generally do not provide the same drug kinetics as would be found in humans
Extensive research continues to find catalytic methods and straightforward syntheses for biological
pathogenic Teff cells and towards the generation of protective T regulatory (Treg) cells. PD-1/PD-L1 immune checkpoint pathway plays an important role in the Teff and Treg balance ... with demonstrated clinical efficacy…
structural changes of white matter and cognitive impairment in patients with Parkinson’s Disease (PD). Methods: 60 patients with PD were selected between January 2013 and December 2015. All patients ... were divided…
most cases, is palliative in nature. This case highlights the potential for PD-1 immunotherapy as both a rapid and durable treatment for lymphangitic carcinomatosis
based on the existence of tumor-infiltrating lymphocytes (TILs) and programmed death-ligand 1 (PD-L1); type I (TILs+/PD-L1+), type II (TILs-/PD-L-), type III (TILs-/PD ... type IV (TILs+/PD-L1-). These immunogenic…
expression profile of costimulatory molecules in host cells. CVB3 infection caused the decrease of PD-1 ligand expression, partially due to the cleavage of AU-rich element binding protein AUF1 ... viral protease 3Cpro…
The main endeavor of the study is to examine the antiparkinsonian effect
Mutations in leucine-rich repeat kinase 2 (LRRK2) are associated with familial and sporadic PD. How LRRK2 interacts with synaptic proteins, and its role in dopamine (DA) homeostasis, synaptic vesicle ... multimeric…
solid complexes of Pd(II),Pt(IV),V(III) and Ru(III) with Schiff base ligand(HL) derived from heterocyclic compounds 3-acetyl-6- methyl-(2H)-pyran ... suggest that the V(III)and Ru(III) complexes have octahedral geometry…
include low level Pt and Pt free ternary combinations of Co and Ni with Pd, supported on vulcan XC-72 for use as anode component in a Direct Ethanol Fuel ... CO32Ã?¢Ã?Â?Ã?Â? is obtained with the Pd, Co, Ni/C catalyst…
important role in the etiology of a subset of SCCHN. The degree of PD-L1 expression has been reported to be increased in those patients with HPV-positive disease. Recent ... clinical studies having shown efficacy of…
PD-L1 and PD-1 inhibitors have achieved great success in the treatment of patients of a wide spectrum of cancers. However, only a fraction of cancer patients benefits from ... tumor growth in several tumor types. More…
poor outcomes. Immune checkpoint inhibitors, in particular those for the programmed cell death protein (PD-1) pathway, have bought great progress for the care of these patients in the past ... decade. Currently, the…
Background: Although immune checkpoint inhibitors improve survival in patients with melanoma and
Parkinson?s disease (PD) is the second most common neurodegenerative disorder that affects 1% of the general population over the age of 60 [1]. PD is characterized by progressive dopamine ... neuron degeneration leads…
Objective: We have previously shown changes in protein, immune cell, nitric oxide
available receptors during patient dosing, as well as to deliver PK data for PK/PD work. For many biologics, flow cytometry assays utilizing peripheral blood are well suited for receptor
Peritonitis is one of the most serious complication of peritoneal dialysis (PD), causing significant morbidity and occasional mortality. Intraperitoneal (IP) administration of antibiotics is recommended for the…
A 76 -year-old male with history of multifocal melanoma involving maxillary
usually caused by the high expression of negative immune-regulatory molecules in tumor microenvironment. PD-L1 has been identified as negative checkpoint molecules that promote immune evasion of tumor cells…
For authors and organisers
Find the right journal for your paper and submit your manuscript.